PureTech Health Proposes $100M Shareholder Capital Return

Ticker: PTCHF · Form: 6-K · Filed: Mar 19, 2024 · CIK: 1782999

Puretech Health PLC 6-K Filing Summary
FieldDetail
CompanyPuretech Health PLC (PTCHF)
Form Type6-K
Filed DateMar 19, 2024
Risk Levelmedium
Pages2
Reading Time2 min
Key Dollar Amounts$100 million, $100 Million
Sentimentneutral

Sentiment: neutral

Topics: capital-return, shareholder-return, announcement

Related Tickers: PRTC

TL;DR

PureTech Health is giving back up to $100M to shareholders.

AI Summary

On March 19, 2024, PureTech Health plc announced a proposed capital return of up to $100 million to its shareholders. The company, listed on LSE and Nasdaq under ticker PRTC, is a pharmaceutical preparations company based in Boston, MA.

Why It Matters

This significant capital return could signal confidence from PureTech Health's management in the company's financial health and future prospects, potentially impacting shareholder value.

Risk Assessment

Risk Level: medium — The proposed capital return is a significant financial event that could impact the company's future investment capacity and operational flexibility.

Key Numbers

  • $100 million — Proposed Capital Return (Amount to be returned to shareholders)

Key Players & Entities

  • PureTech Health plc (company) — Registrant
  • PRTC (company) — Ticker symbol for PureTech Health plc on LSE and Nasdaq
  • $100 million (dollar_amount) — Proposed capital return to shareholders
  • March 19, 2024 (date) — Date of announcement

FAQ

What is the proposed capital return amount?

PureTech Health plc announced a proposed capital return of up to $100 million to its shareholders.

When was this capital return announced?

The announcement was made on March 19, 2024.

What are the ticker symbols for PureTech Health plc?

PureTech Health plc trades on the LSE and Nasdaq under the ticker symbol PRTC.

Where is PureTech Health plc's principal executive office located?

The company's principal executive office is located at 6 Tide Street, Suite 400, Boston, Massachusetts 02210.

Does PureTech Health plc file annual reports under Form 20-F?

Yes, the company indicated it files annual reports under Form 20-F.

Filing Stats: 515 words · 2 min read · ~2 pages · Grade level 13.4 · Accepted 2024-03-19 08:30:25

Key Financial Figures

  • $100 million — nced a proposed capital return of up to $100 million to its shareholders by way of a tender
  • $100 Million — arch 19, 2024, titled PureTech Proposes $100 Million Capital Return. SIGNATURES Pursuant

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PURETECH HEALTH PLC Date: March 19, 2024 By: /s/ Daphne Zohar Name: Daphne Zohar Title: Chief Executive Officer

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.